Procter & Gamble Health Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Jun ' 23	Jun ' 22	Jun ' 21	Jun ' 20	Mar ' 20

Sales

1,229.62

1,114.41

1,008.73

1,355.86

1,154.70

Operating profit

323.95

267.68

246.02

315.41

262.32

Interest

0.77

0.42

0.80

29.45

-

Gross profit

341.57

280.45

263.32

354.85

320.53

EPS (Rs)

138.23

115.98

106.51

153.06

123.63

Other income

18.39

13.19

18.10

68.89

58.21

Stock adjustment

2.85

-4.75

4.54

-13.03

-9.52

Raw material

319.23

323.72

289.12

416.10

363.33

Power and fuel

-

-

-

-

-

Employee expenses

206.17

167.56

153.61

182.93

147.36

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

377.42

359.47

315.45

454.45

391.21

Provisions made

-

0.73

-

-

-

Depreciation

27.37

27.08

30.04

-

21.40

Taxation

84.73

60.85

56.48

100.77

93.90

Net profit / loss

229.47

192.52

176.80

254.08

205.22

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

16.60

16.60

16.60

16.60

16.60

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

26.35

24.02

24.39

23.26

22.72

GPM (%)

27.37

24.87

25.64

24.91

26.43

NPM (%)

18.39

17.07

17.22

17.83

16.92